|
|
Article: Endocare Expands Agreement To Distribute 15-Minute PSA Test To Urologists.(Brief Article)
- Article from:
- Cancer Weekly
- Article date:
- November 6, 2001
CopyrightCOPYRIGHT 2001 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2001 NOV 6 - (NewsRx.com & NewsRx.net) -- Endocare Inc. (ENDO), a developer of temperature-based treatments for prostate cancer and prostate obstruction, has signed a new expanded distribution agreement with privately held Carlsbad, CA-based Qualigen Inc. Under the new agreement, the Endocare sales force will now sell Qualigen's FDA-cleared, 15-minute total prostate specific antigen (PSA) test as a stand-alone product, nonexclusively directly to urology practices. The test, which provides rapid, fully automated, laboratory-quality PSA test results in physician office laboratories, eliminates patient anxiety that can result from delays in receiving test results.
...